In vitro evaluation of a hybrid drug delivery nanosystem for fibrosis prevention in cell therapy for Type 1 diabetes.
Nanomedicine (Lond). 2023 Mar 20. doi: 10.2217/nnm-2022-0231. Online ahead of print.
Nanomedicine (Lond). 2023.
PMID: 36938861